Cayron AF, Morel S, Azam M, Haemmerli J, Aoki T, Bijlenga P, Allémann E, Kwak BR. Enhanced intracranial aneurysm development ...

PYC Therapeutics has concluded the first cohort dosing of healthy volunteers in the Phase Ia single ascending dose (SAD) ...

Novartis’ $1.7 billion Regulus Therapeutics buyout last month came after a hard-fought battle in which the Swiss pharma and ...

Even though National Kidney Awareness Month (March) is over, for those who live with kidney disease the awareness is 24/7.

For ten years, a local 5K run and walk has been making a difference in the world of kidney disease. The Jackrabbit Jog has been chipping away, slowly raising money for a deadly disease thousands have, ...

Callie became pregnant through in vitro fertilization (IVF), a decision she and her husband made to ensure their baby girl would be free of Polycystic Kidney Disease (PKD). “It is an autosomal ...

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental drug to treat a life-threatening kidney disease.